Press Releases on December 10, 2022 - EIN Presswire - Press Release Distribution Service

Published on December 10, 2022 - 20:26 GMT

Cat and Opossum Teach Humans Kindness in New Book

Important Human Values Taught by Animals in Entertaining Poetry Book TORONTO, ONTARIO, CANADA, December 10, 2022 /⁨EINPresswire.com⁩/ -- What would a cat do if she is about to give birth but without a home? Will an opossum, a totally different …

Distribution channels: Book Publishing Industry ...

Published on December 10, 2022 - 20:26 GMT

NWANGANGA SHIELDS: FINDING LOVE

A tale between two interracial lovers to help raise awareness that love knows no race, societal status, distance, and even age. TORONTO, ONTARIO, CANADA, December 10, 2022 /⁨EINPresswire.com⁩/ -- There is nothing better than finding love with an …

Distribution channels: Book Publishing Industry ...

Published on December 10, 2022 - 20:25 GMT

NWANGANGA SHIELDS: A DREAM TO FULFILL

Nwanganga Shields pens an intriguing tale of a young woman named Ejituru and her aspiration to become a doctor TORONTO, ONTARIO, CANADA, December 10, 2022 /⁨EINPresswire.com⁩/ -- Dreams are something sentimental that people want to achieve in their lives, …

Distribution channels: Book Publishing Industry ...

Published on December 10, 2022 - 20:20 GMT

SIX SHORT STORIES FOR CHILDREN

Author Marilyn Wassmann writes and illustrates short stories for children. TORONTO, ONTARIO, CANADA, December 10, 2022 /⁨EINPresswire.com⁩/ -- Marilyn Wassmann’s “What The Wind Blew In” is a children’s book composed of six short stories illustrated by …

Distribution channels: Book Publishing Industry ...

Published on December 10, 2022 - 20:19 GMT

Valuable Lessons Brought Out in “The Opossum and the Cats”

Fun Characters, Beautiful Story Hopes to Give Inspiration to all Humans TORONTO, ONTARIO, CANADA, December 10, 2022 /⁨EINPresswire.com⁩/ -- Because of the presence of digital technology, many people have lost the essence of poetry and literature. Because …

Distribution channels: Book Publishing Industry ...

Published on December 10, 2022 - 20:11 GMT

A New Louisville-based Company Strives to Spread Everyday Elegance With Embroidered Linen Napkins

Customers seeking truly unique handmade gifts can now order artisan linen cocktail napkins from a women-owned company in Louisville. LOUISVILLE, KENTUCKY, UNITED STATES, December 9, 2022 /⁨EINPresswire.com⁩/ -- A new business based in Kentucky is on a …

Distribution channels: Consumer Goods, Gifts, Games & Hobbies ...

Published on December 10, 2022 - 20:09 GMT

A FEW GENERATIONS’ WORTH OF CREATIVE DEVELOPMENT

Poetic skills passed down through the generations in Marilyn Wassmann's family. TORONTO, ONTARIO, CANADA, December 10, 2022 /⁨EINPresswire.com⁩/ -- Some things truly run in the family, like character, skills, and talents. Just like Marilyn B. Wassmann …

Distribution channels: Book Publishing Industry ...

Published on December 10, 2022 - 20:05 GMT

SIX-COMPELLING TALES FOR CHILDREN

Author Marilyn Wassmann composes a collection of short stories for children. TORONTO, ONTARIO, CANADA, December 10, 2022 /⁨EINPresswire.com⁩/ -- "What The Wind Blew In" is a children’s book composed of six short stories filled with terrific …

Distribution channels: Book Publishing Industry ...

Published on December 10, 2022 - 20:05 GMT

Children’s Poetry Made Extra Entertaining

Be Mesmerized by the Adorable Story and Rhymes of “The Opossum and the Cats” TORONTO, ONTARIO, CANADA, December 10, 2022 /⁨EINPresswire.com⁩/ -- Who says Children’s poetry is boring? While every parent hopes to bring valuable lessons to their children …

Distribution channels: Book Publishing Industry ...

Published on December 10, 2022 - 20:04 GMT

A FAMILY OF CREATIVES

Author Marilyn Wassmann presents a collection of poems to which she and her family have contributed. TORONTO, ONTARIO, CANADA, December 10, 2022 /⁨EINPresswire.com⁩/ -- Marilyn Wassmann is a multifaceted artist and writer. She can undoubtedly create …

Distribution channels: Book Publishing Industry ...

Published on December 10, 2022 - 20:00 GMT

Oncternal Therapeutics Presents Updated Interim Data for Zilovertamab in Combination with Ibrutinib at ASH 2022

Updated MCL and CLL data from the ongoing Phase 1/2 study of zilovertamab and ibrutinib are encouraging and continue to improve over prior reporting The ORR of 89% and CR rate of 43% for patients with MCL treated with zilovertamab plus ibrutinib compare …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on December 10, 2022 - 20:00 GMT

Affimed Reports Topline Data from AFM13 Monotherapy Phase 2 REDIRECT Study in Patients with Relapsed or Refractory Peripheral T ...

Data from REDIRECT establish that AFM13 monotherapy is effective in the treatment of relapsed/refractory peripheral T cell lymphoma (r/r PTCL) patients with a differentiated safety profile AFM13 demonstrated robust activity on the primary end point with an …

Distribution channels: Technology

Published on December 10, 2022 - 19:51 GMT

Bristol Based PPC Company Jarrett Digital celebrates 2nd year in business

Jarrett Digital is celebrating their 2nd successful year in business in Bristol. BRISTOL, BRISTOL, UK, December 10, 2022 /⁨EINPresswire.com⁩/ -- Jarrett Digital are celebrating the end of its second successful year in business. The company was set up in …

Distribution channels: Business & Economy, Companies ...

Published on December 10, 2022 - 19:50 GMT

NWANGANGA SHIELDS: SIBLINGS REUNITED

Nwanganga Shields pens a narrative about six siblings coming together as adults after spending many years growing up apart in different places. TORONTO, ONTARIO, CANADA, December 10, 2022 /⁨EINPresswire.com⁩/ -- There is nothing better than a family's …

Distribution channels: Book Publishing Industry ...

Published on December 10, 2022 - 19:46 GMT

Fate Therapeutics Highlights iPSC-derived, Off-the-shelf CAR NK Cell Programs for Multiple Myeloma at 2022 ASH Annual Meeting

Interim Phase 1 Data of FT576 BCMA-targeted Product Candidate Show Clinical Activity in Initial Single-dose Escalation Cohorts as Monotherapy and in Combination with Daratumumab Preclinical Data under Janssen Collaboration with FT555 GPRC5D-targeted …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on December 10, 2022 - 19:38 GMT

ImmunoGen Presents Findings from Expansion Cohorts in Phase 1b/2 Study of Pivekimab Sunirine with Vidaza® and Venclexta® in Acute ...

Broad Anti-Leukemia Activity in Relapsed/Refractory and Frontline AML Presented in Oral Session Recommended Phase 2 Dose Well-Tolerated; Determination of Optimal Venclexta Duration Ongoing in Separate Cohorts ImmunoGen, Inc. IMGN, a leader in the …

Distribution channels: Banking, Finance & Investment Industry

Published on December 10, 2022 - 19:38 GMT

Kura Oncology Presents Updated Clinical Data from KOMET-001 Trial of Menin Inhibitor Ziftomenib at American Society of Hematology ...

– 30% CR rate at 600 mg in 20 patients with relapsed/refractory NPM1-mutant AML – – Low frequency of differentiation syndrome, including 5% rate (1/20) of ≥ Grade 3 among NPM1-mutant patients treated at 600 mg – – 600 mg determined as recommended Phase 2 …

Distribution channels: Banking, Finance & Investment Industry

Published on December 10, 2022 - 19:38 GMT

Sutro Biopharma Announces Presentation of STRO-002 Data from the Compassionate Use Program in Pediatric Patients with Relapsed/...

- A total of 17 pediatric patients were treated with STRO-002 on a compassionate use basis; eight patients achieved complete remission, of which seven patients were MRD negative - - Safety and efficacy profile in this patient population provides added …

Distribution channels: Banking, Finance & Investment Industry

Published on December 10, 2022 - 19:38 GMT

ROSEN, A LEADING LAW FIRM, Encourages Rite Aid Corporation Investors With Losses Over $100K to Secure Counsel Before Important ...

New York, New York--(Newsfile Corp. - December 10, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Rite Aid Corporation RAD between April 14, 2022 and September 28, 2022, both dates inclusive (the …

Distribution channels: Banking, Finance & Investment Industry

Published on December 10, 2022 - 19:38 GMT

New Results from the Phase 3 GLOW Study of Fixed-Duration Treatment with IMBRUVICA® (ibrutinib) Plus Venetoclax Demonstrate Robust ...

With nearly four years of study follow-up, all-oral, fixed duration IMBRUVICA® + venetoclax reduced the risk of progression or death by 79 percent and demonstrated overall survival (OS) advantage versus chemoimmunotherapy NEW ORLEANS, Dec. 10, 2022 / …

Distribution channels: Banking, Finance & Investment Industry